When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BICX - BioCorRx submits Opioid Use Disorder treatment BICX104's IND to the FDA
BioCorRx Inc.
BioCorRx (BICX) announces that the company has filed an Investigational New Drug ((IND)) application with the U.S. FDA for initiation of a clinical trial of BICX104, a naltrexone pellet implant for the treatment of Opioid Use Disorder ((OUD)).BICX104 is a biodegradable, long-acting subcutaneous pellet of naltrexone being developed in partnership with the National Institutes of Health ((NIH)) and the National Institute on Drug Abuse.